Literature DB >> 28534324

[Strategies of diagnosis and treatment for peritoneal metastasis of gastric cancer].

Pin Liang, Xiang Hu1.   

Abstract

Peritoneal metastasis of gastric cancer is the main cause of death in gastric cancer patients. Peritoneal metastasis of gastric cancer is difficult to diagnose in its early stage due to lack of obvious clinical signs and symptoms, and poor treatment outcomes and prognosis are often associated with late stage peritoneal metastasis. Therefore, it is crucial to utilize effective early diagnostic tools and to improve the long-term outcomes and the prognosis of patients with advanced gastric cancer. Recently, systemic chemotherapy and intraperitoneal chemotherapy are the first line therapy, and cytoreductive operation plus abdominal cavity thermochemotherapy may be the best method in the treatment of peritoneal metastasis. However, conversion therapy has been gradually incorporated into the treatment of peritoneal metastasis of gastric cancer because of the better efficacy and the higher survival.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28534324

Source DB:  PubMed          Journal:  Zhonghua Wei Chang Wai Ke Za Zhi        ISSN: 1671-0274


  2 in total

1.  Effects of high-quality nursing intervention on negative emotions, postoperative complications and gastrointestinal function in patients with gastric cancer surgery.

Authors:  Jie Hu; Lu-Lu Wang; Ya Li
Journal:  Am J Transl Res       Date:  2022-03-15       Impact factor: 4.060

2.  Plasma exosome-encapsulated microRNA-21 and microRNA-92a are promising biomarkers for the prediction of peritoneal recurrence in patients with gastric cancer.

Authors:  Naruyoshi Soeda; Hisae Iinuma; Yusuke Suzuki; Daisuke Tsukahara; Hironori Midorikawa; Yuichi Igarashi; Yoshimasa Kumata; Masahiro Horikawa; Takashi Kiyokawa; Takeo Fukagawa; Ryoji Fukushima
Journal:  Oncol Lett       Date:  2019-09-04       Impact factor: 2.967

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.